Delos Wealth Advisors’s Thermo Fisher Scientific TMO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-2
Closed -$1.16K 308
2025
Q4
$1.16K Hold
2
﹤0.01% 237
2025
Q3
$971 Hold
2
﹤0.01% 264
2025
Q2
$811 Buy
+2
New +$836 ﹤0.01% 252
2024
Q3
Sell
-10
Closed -$5.53K 346
2024
Q2
$5.53K Hold
10
0.01% 154
2024
Q1
$5.81K Buy
10
+8
+400% +$4.49K 0.01% 152
2023
Q4
$1.06K Hold
2
﹤0.01% 185
2023
Q3
$1.11K Hold
2
﹤0.01% 213
2023
Q2
$1.04K Hold
2
﹤0.01% 213
2023
Q1
$1.15K Hold
2
﹤0.01% 217
2022
Q4
$1.1K Hold
2
﹤0.01% 228
2022
Q3
$1K Buy
+2
New +$1.12K ﹤0.01% 276
2022
Q1
Sell
-30
Closed -$20K 414
2021
Q4
$20K Buy
+30
New +$18.7K 0.02% 134

Other funds holding TMO

Delos Wealth Advisors's TMO Position: Q1 2026 in Review

Delos Wealth Advisors sold out of Thermo Fisher Scientific (TMO) in Q1 2026, closing a stake of 2 shares — an estimated $1.16K sold.

Delos Wealth Advisors first reported a position in TMO in Q4 2021 and held it in 12 quarters. The position peaked at $20K in Q4 2021. 2,587 funds tracked by Wall St. Rank hold TMO as of Q1 2026.

  • Delos Wealth Advisors reported no remaining Thermo Fisher Scientific position as of Q1 2026 after selling out during the quarter.
  • Delos Wealth Advisors sold 2 Thermo Fisher Scientific shares in Q1 2026, an estimated $1.16K.
  • Delos Wealth Advisors first reported a position in Thermo Fisher Scientific in Q4 2021 and held it in 12 quarters.
  • Delos Wealth Advisors's Thermo Fisher Scientific position peaked at $20K in Q4 2021.
  • 2,587 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q1 2026.

Based on Delos Wealth Advisors's 13F filing for Q1 2026, filed 14 May 2026.